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INTRODUCTION
Most ofwhat we know about gastroe-
sophageal reflux disease (GERD)b sug-
gests that it is caused by disordered neuro-
muscular function in the esophageal body
and in the lower esophageal sphincter
(LES) separating itfrom the stomach. This
implies thatkeeping gastric contents outof
the esophagus in patients with reflux
should restore normality and cure GERD.
However, for most of this century, suc-
cessful therapy ofGERD has usually been
based on reducing acidity of the gastric
(and hence esophageal) contents and
ignoring neuromuscular dysfunction.
Much effort has been expended on
trying to distinguish between direct injuri-
ous effects of acid on the esophageal
mucosa and indirect effects due the effects
of acid on some other component of the
refluxate, rendering the latter more or less
injurious under conditions ofvarying acid-
ity. Despite the considerable success of
potent proton pump inhibitors (PPIs) in
treating GERD, there is in every treatment
trial a group of 5 to 15 percent of those
admitted who continue to have heartburn
despite virtually complete suppression of
gastric acid secretion. This article will
review what we know about refluxate-
medicated injury to the mucosa over the
pH range 1.0 to 8.5.
EXPERIMENTAL STUDIES
Taking off from the work of
Wangensteen in the 1950s [1-3], Redo and
colleagues performed the seminal studies
of the modern era in 1959 [4]. In isolated
esophageal segments in dogs, they
showed that perfusing with strongly
acidic gastricjuice (pH 2.10) led to ulcer-
ation in 88 percent of animals, but when
pH was between 2.10 and 3.0, injury was
reduced; at pH > 3.0 there was little or no
injury. When peptic activity of the juice
was reduced or abolished by 0.1 N. NaOH
and reacidification to pH 2.1, or by boil-
ing prior to use, there was no injury.
Similarly, perfusion with dilute
hydrochloric acid alone (pH . 2.0) or acid
plus 0.1 percent pepsin caused no injury.
a To whomallcorrespondence shouldbeaddressed: Denis M. McCarthy, M.D., VA Medical
Center 111 F, 1501 San Pedro S.E., Albuquerque, NM 87108.Tel.: 505-256-2801; Fax: 505-
256-5751; E-mail: denis.mccarthy2@med.va.gov.
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However, when pepsin concentration in
the same perfusate was raised to 2 per-
cent, severe ulceration developed in over
80 percent ofanimals and esophageal per-
foration in 15 percent. All regions of the
esophagus were similarly sensitive to
injury.
Paradoxically, when pepsin concen-
tration was raised to 10 percent, injury was
much reduced at pH of less than 2.0, and
absent at higher pH. Perfusing these seg-
ments with pure human bile, human pan-
creatic juice or mixtures of these together
or of bile plus gastric juice produced little
or no injury. From these studies pepsin
seemed to be the major agent ofinjury, but
the injury appeared to depend both on pH
and pepsin concentration. Furthermore,
dialysis of gastric juice prior to perfusion
studies greatly increased its capacity to
cause injury, suggesting that dialysis had
removed either a pepsin-inhibitor or some
endogenous protective substance(s) pre-
sent in the juice, e.g. prostaglandins or
phospholipids. Similarly, addition of bile
to gastric juice reduced injury. These
observations still remain unexplained.
This work was confirmed and extend-
ed by Goldberg and Dodds [5], using
porcine pepsin in the cat esophagus per-
fused for 1 hour. At pH 1 and pH 1.3, acid
alone caused esophagitis. At pH above 1.3,
acid alone caused no injury, but addition of
pepsin caused immediate injury maximum
at the pH optimum of the enzyme (1.3 to
1.6). When the pepsin inhibitor Depepsin
was added to the perfusate, no injury
occurred. Since esophageal pH is usually
above 2.0 in GERD patients, these studies
supported the notion that acid acted by
activating pepsinogen to pepsin, leading to
proteolytic degradation of the mucosal
surface. This, however, does not exclude
the possibility that, in the mucosa thus
damaged, back diffusion of acid exacer-
bated the injury; at high acid concentra-
tions, pepsin was not essential to produc-
ing injury.
Over the next 15 years, initial opti-
mism about the effectiveness ofcimetidine
in GERD gradually gave way to the real-
ization that in many cases even quite high
doses of the drug produced little or only
transient symptom relief. Furthermore,
over the previous 25 years there had been
a growing realization that heartburn and
GERD occasionally occurred in the virtu-
al absence of gastric acid, as in patients
with pernicious anemia or with achlorhy-
dria following gastric surgical procedures.
This prompted a resurgence of inter-
est in the contributions of bile salts and
alkaline reflux to esophagitis by workers
at Walter Reed Army Hospital [6-8].
Studies by Harmon et al. [6] clarified some
important questions about bile salts. In the
perfused rabbit esophagus (without
pepsin) they showed that at pH 2.0 conju-
gated bile acids (salts) disrupted the
mucosal barrier while unconjugated bile
acids did not. However, at pH 7.0, uncon-
jugated bile acids also disrupted the barri-
er. They established that when the per-
fusate pH was less than the pKa ofthe bile
acid it precipitated and caused no damage;
however, when pKa was less than the pH
of perfusate, the bile acid solubilized and
caused injury. The studies revealed that the
mucosa was very sensitive to bile acids in
solution (as low as 3 mM disrupted the
barrier) and showed no ability to recover
from such injury [6].
Next, using a continuously perfused
rabbit esophagus, they studied the poten-
tially injurious effects of trypsin, tau-
rodeoxycholate and pepsin atpH 7.5 while
measuring both macroscopic mucosal
injury and esophageal mucosal barrier
function [7]. The latter was assessed by
measuring net fluxes of hydrogen ion,
potassium, glucose, water and hemoglobin
into/out of the perfused lumen. As judged
by pathological injury, trypsin caused the
most severe mucosal damage and bleeding
(at close to its pH optimum, 8.1) but
caused only minimal alteration in barrierMcCarthy: Acid and the esophagus 127
function; pepsin or test solution caused no
injury at this pH.
In contrast, taurodeoxycholate, which
caused little apparent mucosal injury,
caused profound disruption of barrier
function in the apparently uninjured
mucosa, with marked leakage ofhydrogen
ions out of(andpotassium into) the lumen.
Because the normal pH in the esophageal
lumen is 5 to 6, and because reflux ofacid
or alkali is minimal and rapidly cleared
under normal conditions, no injury occurs
with transient reflux in normal subjects.
However, reflux of acid-plus-activated-
pepsin or alkali-plus-activated-trypsin
(potentially derived from pancreatic juice)
can cause considerable injury if not rapid-
ly cleared. While the injury caused by
pepsin occurs only in the presence ofacid,
that oftrypsin can occur in its absence and
causes no leakage of hydrogen ions into
the mucosa. The studies also revealed that
considerable damage to the mucosa - as
judged by grossly impaired barrier func-
tion - could occur in the absence of
macroscopic injury or changes revealed by
light microscopy.
In subsequent studies [8], the same
group showed that the addition of tau-
rodeoxycholate increased the injury
caused by trypsin at pH 7.5 in a dose-
dependent manner, while its addition to a
solution of pepsin at pH 2.0, dose-depen-
dently reduced both the gross and micro-
scopic injury caused by acid-pepsin alone
and also reduced barrier dysfunction.
Lysolecithin can be generated in vivo from
the action of pancreatic phospholipase A
on biliary lecithin. Perfusion ofthe esoph-
agus with lysolecithin also damaged the
esophageal mucosa in the presence but not
in the absence of acid [9], the damage
increasing with acid concentration. From
all these observations, it appeared that
agents such as pepsin, lysolecithin and
conjugated bile salts in solution, caused
esophageal mucosal damage in the pres-
ence ofacid, partly by increasing back-dif-
fusion of hydrogen ions into the mucosa
and partly by direct damage to cells, but
that not all such damage was apparent to
the naked eye. However, the effects ofbile
salts at acid pH seemed to vary with their
pK values, with whether they were conju-
gated or unconjugated, and in the presence
or absence ofpepsin.
On the other hand, the esophagitis
caused by alkaline reflux was trypsin-
mediated and exacerbated in the presence
of bile reflux, particularly when bile acids
were unconjugated. Furthermore, surgical
diversion oftrypsin and duodenal contents
away from the esophagus cured the heart-
burn associated with partial gastrectomy
even in the continued presence of pepsin
[10]. Despite these animal and human
observations, there remained some uncer-
tainty as to the extent to which duodeno-
gastro-esophageal reflux (DGER) con-
tributed to acid-pepsin-mediated esophagi-
tis in intact humans. At about the same
time, Hirschowitz [11], in studies in 155
patients with esophagitis and 508 appro-
priate controls, concluded that neither the
composition of gastric juice in terms of
acid or pepsin, nor the basal or stimulated
outputs of these substances, could be cor-
related with the presence or severity of
esophagitis.
In the past five years, a new fiber-
optic system (Bilitec 2000, Synectics, Inc.
Irving, TX; now Medtronics, Inc.) was
developed that measures gastric and
esophageal concentrations of bilirubin
(and by implication the amount ofDGER)
spectrophotometrically, independent ofpH
[12]. Taking total time at pH less than 4.0
as an indicator of acid reflux, and total
time with bilirubin absorbance at more
than 0.14 as an indicator of DGER, in 30
patients with GERD and in 20 controls, it
was found that both parameters increased
across a spectrum of increasingly severe
GERD. Exposure to both acid and DGER
was the most prevalent pattern in 100 per-
cent of patients with complicated and 89128 McCarthy:Acid and the esophagus
percent of those with uncomplicated
Barrett's esophagus; in 79 percent of
patients with esophagitis; and in 50 per-
cent of GERD patients without esophagi-
tis. These criteria were not met in controls
[13].
In patients there was a strong correla-
tion between percent time at pH < 4.0 and
percent time with bilirubin absorbance >
0.14 (r = 0.73: p < .01). These data indi-
cated that acid (with pepsin) and DGER
occur simultaneously in the majority of
GERD patients. More recent studies in 32
partial gastrectomy patients [14], using the
same methodologies, showed that such
patients formed a heterogeneous group: 28
percent had mixed reflux (acid
+/DGER+), 50 percent had only DGER
(acid-/DGER+), and 22 percent had nei-
ther acid nor DGER (acid-/DGER-). Both
mixed reflux and DGER groups had
GERD symptoms. Patients in the
(acid+/DGER+) mixed group had
esophagitis, but no (acid-) patient had
esophagitis, regardless of the presence or
absence of DGER. DGER alone in the
absence of acid (acid-/DGER+) caused
heartburn but not esophagitis. Although
there are undoubtedly some post-gastrec-
tomy patients in whom esophagitis can be
attributed to trypsin and bile salts [10], in
the majority ofthose with esophagitis acid
is present; DGER did not correlate with
mucosal injury [14]. Furthermore, because
of effects on the volume/output of gastric
secretions, proton pump inhibitor therapy
greatly reduces DGER in GERD patients
[12].
These data support the clinical prac-
tice of first treating post-gastrectomy
reflux with a PPI drug, and only if this
fails considering detailed investigations of
intraesophageal contents and pH, as a pre-
lude to diversionary surgery. "Alkaline
reflux" appears to contribute to heartburn
but not esophagitis. From the finding of
esophagitis only in the acid+/DGR+
group, there appears to be arequirement of
acid for most visible mucosal injury. From
what we know, the acid would activate
pepsin, inactivate trypsin and aid in caus-
ing mucosal injury by lysolecithin and
conjugated bile salts, although the latter
may also result in some inactivation of
pepsin. Thus, we return to the problem of
separating the direct effects of acid from
the indirect effects that it mediates through
interactions with other substances, such as
pepsin, bile salts and lysolecithin. From all
of the above considerations, it appears
unlikely that the effects of acid are con-
fined solely to the activation ofpepsin.
What then do we know of esophageal
injury ordysfunction caused by acid alone?
Since 1977, Orlando and co-workers have
relentlessly pursued this question. Starting
with comparative studies in several species,
they showed thatthe transmucosal potential
difference (PD) and the structure of the
stratified squamous epithelium were very
similar in man and rabbit, justifying the
choice of the rabbit as a useful animal
model for studying human disease [15].
They next showed that continuous perfu-
sion ofthe esophagus with acidledto apro-
gressive decline in PD and a progression of
cellular and epithelial injury, beginning
with swelling of the intercellular spaces,
followed by cell swelling and rupture, and
ultimately epithelial disruption in the area
closest to the entry of acid [15]. Early in
injury, while water is accumulating
between cells on electron microscopy
(EM), mucosal electrical resistance falls,
but sodium transport is not impaired. Later,
withprogression ofinjury, sodium transport
is abolished, followed by marked changes
on EM but no macroscopic change ortrans-
mucosal necrosis. The addition of dilute
pepsin to the perfusate accelerates the
changes but does not change the type or
extent of injury [17]. The injury progres-
sively moves from the stratum corneum, to
the stratum spinosum butrarely deeperthan
this. The pattern of injury, rate of progres-
sion and interference with Na+/K+ATP-aseMcCarthy:Acid and the esophagus 129
activity and sodium transport are all depen-
dent on acid concentration [18]. At lower
concentrations (20 to 40 mm), and early in
injury, there is increased diffusion of H+
from lumen to tissue to blood. Later, and at
higher acid concentrations (80 to 120mm),
loss of ATP-ase activity results in cell
swelling and rupture as in [17].
These observations raised questions
as to what structural components of squa-
mous epithelium formed the barrier
responsible for resistance to the diffusion
of acid into tissues. In extensive micro-
scopic studies employing both EM and
histochemistry [19], the group showed that
acid caused disruption neither ofthe "tight
junctions" or desmosomes, nor ofintercel-
lular lamellar lipid bodies, but instead
seemed to cause destruction or solubiliza-
tion of the dense glycoconjugate material
secreted by cells into the intercellular
spaces. Later, endoscopic biopsies of the
human esophagus, from controls and from
patients with heartburn, were examined by
transmission EM. They showed that dilat-
ed intercellular spaces larger than 2.4 pm
were present in 73 percent of heartburn
patients and in no controls [20]. This find-
ing did not differ in patients with or with-
out visible or histologic erosive esophagi-
tis.
In their most recent studies [21], the
development of symptoms during perfu-
sion of the esophagus with 0.1 N. HCL
was correlated with measurements of PD
(a measure of barrier function, previously
correlated with changes in intercellular
spaces) in four groups of humans: healthy
controls; those with endoscopy-negative
GERD, before and after omeprazole thera-
py; patients with reflux esophagitis (RE);
and GERD patients in remission post-fun-
doplication. The findings were that all
patients with esophagitis developed symp-
toms during acid perfusion, as did 60 per-
cent of those with endoscopy-negative
GERD before therapy, reduced to and 30
percent during therapy. Two of 10 surgi-
cally-treated patients developed mild
symptoms, but none of the controls did.
Although baseline PD measurements dif-
fered in the four groups (lowest in con-
trols, -12mv; highest in RE, -17mv), PD
rose similarly during acid infusion in all
four groups to an extent comparable to the
"early or mild barrier injury" changes
observed in animal studies [18].
These data suggest that symptoms
accompany mild barrier injury during acid
infusion only in subjects with some pre-
existing tissue injury, as revealed by EM
or baseline PD measurements, and that
such changes are more sensitive and spe-
cific for acid injury than are endoscopic
findings on naked eye examination or "on
conventional microscopic examination of
mucosal biopsies." They also raise the pos-
sibility that trans-esophageal measure-
ments of PD, combined with the PD
response to acid infusion, might be sensi-
tive indicators of subclinical esophageal
injury occurring within the range of "nor-
mal" reflux as defined by 24-hour pH-
metry.
Subclinical injury brings us to the
final issues with regard to acid and the
esophagus, namely afferent sensitivity,
pain threshold and patient responsiveness.
In studies of non-referred populations of
heartburn sufferers, esophageal symptom
scores correlate well with percent time at
pH < 4.0 for the total and upright, but not
the supine, time intervals [20]. These 24-
hr pH results were not predictive of the
response to minimum doses ofH2-antago-
nists [22]. Studies by Trimble et al. [23]
showed that esophageal sensory responses
to balloon distension were significantly
increased in those with symptomatic but
not excessive (by 24-hr pH) gastroe-
sophageal reflux, compared to those with
obvious excessive reflux or to asympto-
matic healthy controls. This indicated that
some heartburn patients without
esophagitis had a low threshold for
painful sensation. In contrast, responses toMcCarthy:Acid and the esophagus 130
balloon distension were reduced and sen-
sory thresholds increased significantly in
esophagitis patients with Barrett's
Esophagus compared to the same controls
[23). Interestingly, although the stimulus
was mechanical and not chemical, 55 per-
cent of patients in the hypersensitive
group described the balloon-evoked sen-
sation as identical to their GERD present-
ing symptoms.
In more recent studies in normal vol-
unteers, the pain threshold forresponses to
electrical stimulation in the mid-esopha-
gus was lowered by distal infusion ofacid.
Since acid did not enter the segment under
study, sensitization and hyperalgesia must
have occurred centrally [24]. However,
work from other centers suggests that the
afferent sensory thresholds vary with the
type of stimulus supplied, the type of sen-
sation evoked and the presence or absence
ofpre-existing disease orinjury in the sub-
ject [25]. This work is in its early stages
but is very important. Results will hope-
fully be correlated with changes in PD and
with EM appearances ofthe tissue.
CONCLUSIONS
There is increasing evidence that the
effects of acid in the esophagus can be
grouped as direct and indirect. The pres-
ence of esophagitis as recognized endo-
scopically or by conventional histology
seems to reflect the presence of more
advanced GERD, contributed to by indi-
rect effects of acid on the damage mediat-
ed by pepsin, conjugated bile salts,
lysolecithin and perhaps other substances.
These gross changes may be superim-
posed on subclinical, but functionally sig-
nificant, direct injury by acid to the
mucosa. There is abundant evidence based
on studies of PD, ion fluxes, H+ and Na+
transport, Na+/K+ ATP-ase activity, elec-
tron microscopic and histochemical stud-
ies that acid alone causes significant but
often clinically occult esophageal mucosal
injury. This last may contribute to heart-
burn in patients in whom 24-hour pH stud-
ies fail to show results that meet conven-
tional criteria for reflux. Whether such
subclinical injury also contributes to disor-
dered sensation, altered pain thresholds,
hyperalgesia and dysmotility remains tobe
seen.
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